Article Details

Tafasitamab Plus Lenalidomide/Rituximab Improves PFS in Relapsed/Refractory Follicular ...

Retrieved on: 2024-12-10 22:48:23

Tags for this article:

Click the tags to see associated articles and topics

Tafasitamab Plus Lenalidomide/Rituximab Improves PFS in Relapsed/Refractory Follicular .... View article details on hiswai:

Excerpt

... monoclonal antibodies, and [those] receiving multiple prior lines of therapy. ... monoclonal antibody. An ECOG performance status of 0 to 2 and ...

Article found on: www.onclive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo